XML 30 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share-Based Plans (Details) (USD $)
3 Months Ended
May 04, 2013
Apr. 28, 2012
Feb. 02, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Expense $ 4,600,000 $ 8,100,000  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Weighted-average fair value of stock options granted $ 12.14 $ 15.28  
Risk-free interest rate 0.70% 0.70%  
Expected life (years) 4 years 2 months 12 days 4 years 2 months 12 days  
Expected volatility 42.50% 40.90%  
Expected annual forfeiture rate 3.00% 3.00%  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding stock options, beginning balance 3,029,086    
Options, Grants in Period, Net of Forfeitures 851,000    
Options, Exercises in Period (55,420)    
Options, Forfeitures and Expirations in Period (78,675)    
Outstanding stock options, ending balance 3,745,991    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]      
Options, Vested and Expected to Vest, Outstanding, Number 3,573,069    
Options, Exercisable, Number 1,718,489    
Options, Outstanding, Weighted Average Exercise Price $ 34.97   $ 34.49
Options, Grants in Period, Weighted Average Exercise Price $ 35.72    
Options, Exercises in Period, Weighted Average Exercise Price $ 16.24    
Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price $ 37.72    
Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $ 34.77    
Options, Exercisable, Weighted Average Exercise Price $ 30.33    
Options, Outstanding, Weighted Average Remaining Contractual Term 4 years 9 months 18 days    
Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term 4 years 9 months 18 days    
Options, Exercisable, Weighted Average Remaining Contractual Term 3 years 7 months 6 days    
Options, Outstanding, Intrinsic Value 15,650,000    
Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value 15,527,000    
Options, Exercisable, Intrinsic Value 14,110,000    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]      
Total intrinsic value of stock options exercised 1,040,000 28,122,000  
Total fair value of restricted stock vested 0 21,103,000  
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized $ 49,400,000    
Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition 2 years 3 months 18 days    
Stock Options [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]      
Award Requisite Service Period 4 years    
Share-based Compensation Arrangement by Share-based Payment Award, Award Term 7 years    
Restricted Stock [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]      
Award Requisite Service Period 5 years    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Nonvested, beginning balance 783,609    
Grants in Period 339,500    
Vested in Period 0    
Forfeited in Period (248,300)    
Nonvested, ending balance 874,809    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]      
Nonvested, Weighted Average Grant Date Fair Value $ 39.22   $ 42.25
Grants in Period, Weighted Average Grant Date Fair Value $ 35.54    
Vested in Period, Weighted Average Grant Date Fair Value $ 0.00    
Forfeited in Period, Weighted Average Grant Date Fair Value $ 43.75    
Share Based Awards 2012 [Member] | Initial [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]      
Award Vesting Period 3 years